Neil Kumar

BBIO

Neil Kumar serves as director, officer: Chief Executive Officer at BridgeBio Pharma, Inc. (BBIO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

52 trades

$146.74M

Net Position

Net Seller

$146.74M

Companies Traded

BBIO

Active Period

May 2021 – Sep 2026

52 total trades

Most Recent

Sell BBIO

Sep 21, 2026 · $690.8K

Neil Kumar's Insider Trading at BridgeBio Pharma, Inc. (BBIO)

Buys

0 · $0.00

Sells

2 · $384.8K

Total Shares Bought

Total Shares Sold

7,461

BBIO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 16, 2021	Sell	3,730	$49.48	$184.6K	0
May 16, 2021	Sell	3,731	$53.66	$200.2K	0

Showing 51–52 of 52

Related Insiders

Maricel Apuli

officer: Chief Accounting Officer

BBIOSell · Aug 3, 2026

Andrea Ellis

director

BBIOSell · Jul 13, 2026

Jennifer E. Cook

director

BBIOSell · Jul 13, 2026

Hannah Valantine

Director

BBIOSell · Jun 24, 2026

Randal W. Scott

Director

BBIOSell · May 19, 2026

Thomas Trimarchi

President and CFO

BBIOSell · May 19, 2026

Andrew Lo

Director

BBIOSell · Nov 17, 2025

DANIELS RONALD J

Director

BBIOSell · Nov 6, 2025

Explore More Insider Trading Data

BBIO Insider Trading Activity

View all insider trades at BridgeBio Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity